Toralf Brüning1, Mohamed Al-Khaled. Show Affiliations » 1. Department of Neurology, University of Lübeck, Lübeck, Germany.
Abstract
Entities: Disease
Mesh: See more » AgedBrain Ischemia/drug therapyCerebral Hemorrhage/chemically inducedCerebral Hemorrhage/diagnosisCerebral Hemorrhage/epidemiologyFemaleFibrinolytic Agents/adverse effectsFibrinolytic Agents/therapeutic useHealth Status IndicatorsHumansMalePrognosisRecombinant Proteins/adverse effectsRecombinant Proteins/therapeutic useRiskStroke/drug therapyThrombolytic Therapy/adverse effectsTissue Plasminogen Activator/adverse effectsTissue Plasminogen Activator/therapeutic use
Substances: See more » Fibrinolytic AgentsRecombinant ProteinsTissue Plasminogen Activator
Year: 2015 PMID: 25622691 PMCID: PMC6495188 DOI: 10.1111/cns.12376
Source DB: PubMed Journal: CNS Neurosci Ther ISSN: 1755-5930 Impact factor: 5.243